West Pharmaceutical Services, Inc.
WST
$218.58
$7.153.38%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -6.78% | 0.25% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.78% | 0.25% | |||
| Cost of Revenue | -1.91% | -1.45% | |||
| Gross Profit | -15.24% | 3.36% | |||
| SG&A Expenses | 3.96% | 1.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -100.00% | |||
| Total Operating Expenses | -1.33% | -0.55% | |||
| Operating Income | -25.09% | 3.06% | |||
| Income Before Tax | -31.76% | -0.89% | |||
| Income Tax Expenses | -34.51% | 13.58% | |||
| Earnings from Continuing Operations | -30.98% | -4.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -30.98% | -4.34% | |||
| EBIT | -25.09% | 3.06% | |||
| EBITDA | -20.61% | 2.71% | |||
| EPS Basic | -30.79% | -4.21% | |||
| Normalized Basic EPS | -23.95% | 4.56% | |||
| EPS Diluted | -31.02% | -3.62% | |||
| Normalized Diluted EPS | -23.84% | 4.56% | |||
| Average Basic Shares Outstanding | -0.28% | -0.14% | |||
| Average Diluted Shares Outstanding | -0.41% | -0.14% | |||
| Dividend Per Share | 0.00% | 5.00% | |||
| Payout Ratio | 0.44% | 0.10% | |||